E Fund Management Co., Ltd. Adagene Inc. Transaction History

E Fund Management Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.24 - $2.09 $11,160 - $18,810	-9,000 Reduced 46.61%	10,310 $13,000
Q1 2022 May 12, 2022	SELL	$3.5 - $8.79 $121,712 - $305,672	-34,775 Reduced 64.3%	19,310 $69,000
Q4 2021 Feb 11, 2022	SELL	$7.4 - $14.44 $33,929 - $66,207	-4,585 Reduced 7.81%	54,085 $433,000
Q3 2021 Nov 12, 2021	BUY	$12.7 - $20.68 $745,109 - $1.21 Million	58,670 New	58,670 $851,000

9.87M

Ticker ADAG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,423,200
Market Cap $96M
Description
Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.